Advertisement
Advertisement

KYMR

KYMR logo

Kymera Therapeutics, Inc. Common Stock

80.61
USD
Sponsored
-0.04
-0.05%
May 21, 16:00 UTC -4
Closed
exchange

After-Market

80.62

+0.01
+0.01%

Kymera Therapeutics, Inc. Common Stock Profile

About

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

Info & Links

CEO

Nello Mainolfi

Headquarters

500 North Beacon Street, 4th Floor
Watertown, MA 02472, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kymeratx.com

Auditor

Ernst & Young LLP

Share holders

10

Employees

238

Kymera Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.63B

Enterprise Value

6.49B

Enterprise Value/EBITDA(ttm)

-18.03

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

181.87

Price to Book(mrq)

4.50

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-784.21%

Profit Margin(ttm)

-1741.76%

Return on Equity(ttm)

-28.71%

Return on Invested Capital(ttm)

-30.36%

Return on Assets(ttm)

-25.13%

Income Statement

Revenue(ttm)

51.48M

Revenue Per Share(ttm)

0.63

Gross Profit(ttm)

51.48M

EBITDA(ttm)3

-359.92M

Net Income Available to Common(ttm)

-315.00M

Diluted EPS(ttm)

-3.68

Share Statistics

Beta (5Y Monthly)

2.28

52-Week Change

156.39%

S&P 500 52-Week Change

27.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

82.26M

Dividend Yield

0.00%

Float4

68.57M

% Held by Insiders

16.01%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

650.93M

Total Cash Per Share(mrq)

7.91

Total Debt(mrq)

2.85M

Total Debt/Equity(mrq)

0.21%

Current Ratio(mrq)

10.47%

Quick Ratio(mrq)

10.47%

Book Value Per Share(mrq)

19.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.76

Free Cash Flow(ytd)

-234.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement